Thursday, January 1, 2026 1/1/2026

Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals

Award Number: R01MH135403
ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 11/08/2023
PERIOD OF PERFORMANCE END DATE: 10/31/2028

Group Awards By:

View Award Description

Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals - Project Summary Three-dimensional (3D) brain organoids from human pluripotent stem cells (hPSCs) provide a tremendous opportunity to model brain development and disease. Over the last few years, we have developed many hPSC-based protocols that now enable researchers to routinely generate > 50 distinct human cell types for modeling both Central Nervous System and Peripheral Nervous System disorders in a dish. More recently, our lab and others have translated those 2D approaches into 3D “guided” neural organoid protocols to generate specific regions of the human brain. Further complexity can be achieved by combining individual organoids into multi-region assembloids, or by spatially restricted patterning to induce distinct human brain regions within a single organoid. However, currently available organoid and assembloid models have major limitations, including a poor representation of several progenitor and neuronal cell populations such as outer radial glia (oRG) and several cortical interneuron lineages. We posit that the missing or underrepresented cell types may depend on signals provided by non-neural lineages (vascular and immune cells). In our preliminary work, we have developed an improved hPSC-based cortical organoid model which dramatically enhances the generation of oRG, cortical-derived interneurons, and cortical excitatory neurons with increased levels of maturity. This was achieved by treatment with leukemia inhibitor factor (LIF) resulting in the activation of STAT3 and mTOR signaling pathways. Data from human fetal cortex development identifies vascular pericytes are a major source of LIF. Remarkably, we demonstrate that integrating hPSC-derived brain pericytes can substitute for LIF treatment in cortical organoids. Here, in Aim 1 we will optimize and assess robustness of the LIF organoid protocol and the generation of oRG across multiple human PSC lines. We will further assess whether oRG give rise to intermediate progenitors, cortical interneurons and cortical excitatory neurons using a unique oRG-specific double reporter hPSC line and genetic fate mapping tools. Finally, we will determine how changes in mTOR signaling impact oRG behavior and whether phenotypes observed in models of Tuberous Sclerosis (TSC) are linked to aberrant oRG function. In Aim 2, we will build an organoid system that integrates key non-neural cell types. We will establish a modular platform that combines cortical organoids with 3D spheroids (“microtissues”) comprised of vascular brain pericytes and/or microglia. These novel microphysiological platform will be utilized to determine both LIF-dependent and LIF independent effects on cortical development. Finally, we will assess whether such a more complex microphysiological platform will enable improved modeling of the developmental defects related to mTOR signaling and TSC.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $706,519 )
2026	2026	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Mental Health Research Grants	000	3	12/2/2025	NON-COMPETING CONTINUATION	$706,519
														Subtotal = $706,519

Issue Date FY: 2025 ( Subtotal = $706,519 )
2025	2025	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Mental Health Research Grants	000	2	11/26/2024	NON-COMPETING CONTINUATION	$600,540
2025	2025	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Mental Health Research Grants	001	2	9/23/2025	NON-COMPETING CONTINUATION	$105,979
														Subtotal = $706,519

Issue Date FY: 2024 ( Subtotal = $724,048 )
2024	2024	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVENUE	NEW YORK	NY	10065	NEW YORK	USA	Mental Health Research Grants	001	1	5/10/2024	NEW	$72,816
2024	2024	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVENUE	NEW YORK	NY	10065	NEW YORK	USA	Mental Health Research Grants	000	1	11/8/2023	NEW	$655,346
2024	2024	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	1275 YORK AVENUE	NEW YORK	NY	10065	NEW YORK	USA	Mental Health Research Grants	002	1	6/18/2024	NEW	-$4,114
														Subtotal = $724,048

Grand Total All Awards = $2,137,086

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals

Award Number: R01MH135403

ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 11/08/2023

PERIOD OF PERFORMANCE END DATE: 10/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer